1 |
Bavaresco L, Fregoni C, Cantu E, Trevisan M. Stilbene compounds: From the grapevine to wine. Drug Exp. Clin. Res. 25: 57-63 (1999)
|
2 |
Hibasami H, Takagi K, Ishii T, Tsujikawa M, Imai N, Honda I. Induction of apoptosis by rhapontin having stilbene moiety, a component of rhubarb (Rheum officinale Baillon) in human stomach cancer KATO III cells. Oncol. Rep. 18: 347-351 (2007)
PUBMED
|
3 |
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7: 941-946 (2001)
DOI
ScienceOn
|
4 |
Skurk T, Hauner H. Obesity and impaired fibrinolysis: Role of adipose production of plasminogen activator inhibitor-1. Int. J. Obes. Relat. Metab. Disord. 28: 1357-1364 (2004)
DOI
ScienceOn
|
5 |
Cheong HS, Ryu Y, Kim KM. Anti-allergic action of resveratrol and related hydroxyl stilbenes. Planta Med. 65: 266-268 (1999)
DOI
ScienceOn
|
6 |
Regev-Shoshani G, Shoseyov O, Bilkis I, Kerem Z. Glycosylation of resveratrol protects it from enzymic oxidation. Biochem. J. 374: 157-163 (2003)
DOI
ScienceOn
|
7 |
Cernkovich ER, Deng J, Bond MC, Combs TP, Harp JB. Adiposespecific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity. Endocrinology 149: 1581- 1590 (2008)
DOI
ScienceOn
|
8 |
Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem. Pharm. Bull. 30: 1766-1770 (1982)
DOI
PUBMED
ScienceOn
|
9 |
Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscl. Throm. Vas. 24: 29-33 (2004)
DOI
ScienceOn
|
10 |
Ahn J, Lee H, Kim S, Ha T. Resveratrol inhibits TNF-α-induced changes of adipokines in 3T3-L1 adipocytes. Biochem. Bioph. Res. Co. 364: 972-977 (2007)
DOI
ScienceOn
|
11 |
Yamamoto H, Schoonjans K, Auwerx J. Sirtuin functions in health and disease. Mol. Endocrinol. 21: 1745-755 (2007)
DOI
ScienceOn
|
12 |
Lam RY, Woo AY, Leung PS, Cheng CH. Antioxidant actions of phenolic compounds found in dietary plants on low-density lipoprotein and erythrocytes in vitro. J. Am. Coll. Nutr. 26: 233-242 (2007)
PUBMED
|
13 |
Samad F, Yamamoto K, Loskutoff DJ. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo: Induction by tumor necrosis factor-α and lipopolysaccharide. J. Clin. Invest. 97: 37-46 (1996)
DOI
PUBMED
ScienceOn
|
14 |
Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity. Nat. Med. 2: 800-803 (1996)
DOI
ScienceOn
|
15 |
Hung LM, Chen JK, Lee RS, Liang HC, Su MJ. Beneficial effects of astringinin, a resveratrol analogue on the ischemia and reperfusion damage in rat heart. Free Radial Bio. Med. 30: 877-883 (2001)
DOI
ScienceOn
|
16 |
Juhan-Vague I, Alessi MC, Mavri A, Morange PE. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance, and vascular risk. J. Thromb. Haemost. 1: 1575-1579 (2003)
DOI
ScienceOn
|
17 |
Maahs DM, Ogden LG, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson JE, Ehrlich J, Eckel RH, Rewers M. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111: 747-753 (2005)
DOI
ScienceOn
|
18 |
Stephens JM, Morrison RF, Pilch PF. The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J. Biol. Chem. 271: 10441-10444 (1996)
DOI
ScienceOn
|
19 |
Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW, Guarente L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPARgamma. Nature 429: 771-776 (2004)
DOI
PUBMED
ScienceOn
|
20 |
Waffo-Teguo P, Fauconneau B, Deffieux G, Huguet F, Vercauteren J, Merillon JM. Isolation, identification, and antioxidant activity of three stilbene glucosides newly extracted from Vitis vinifera cell cultures. J. Nat. Prod. 61: 655-657 (1998)
DOI
ScienceOn
|
21 |
James PT, Rigby N, Leach R. International obesity task force, The obesity epidemic, metabolic syndrome, and future prevention strategies. Eur. J. Cardiovasc. Prev. Rehabil. 11: 3-8 (2004)
DOI
ScienceOn
|
22 |
Lam KS, Xu A. Adiponectin: Protection of the endothelium. Curr. Diab. Rep. 5: 254-259 (2005)
DOI
ScienceOn
|
23 |
Lyon CJ, Hsueh WA. Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease. Am. J. Med. 115: S62- S68 (2003)
|
24 |
Su L, David M. Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol. J. Biol. Chem. 275: 12661-12666 (2000)
DOI
ScienceOn
|
25 |
Deng J, Hua K, Lesser SS, Harp JB. Activation of signal transducer and activator of transcription-3 during proliferative phases of 3T3- L1 adipogenesis. Endocrinology 141: 2370-2376 (2000)
DOI
ScienceOn
|
26 |
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard- Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. New Engl. J. Med. 355: 763-778 (2006)
DOI
ScienceOn
|
27 |
Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J. Clin. Endocr. Metab. 89: 2595-2600 (2004)
DOI
ScienceOn
|
28 |
Trayhurn P, Wood IS. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Brit. J. Nutr. 92: 347-355 (2004)
DOI
ScienceOn
|
29 |
Piver B, Fer M, Vitrac X, Merllon JM, Dreano Y, Berthow F, Lucas D. Involvement of cytochrome P4501A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem. Pharmacol. 68: 773-782 (2004)
DOI
ScienceOn
|
30 |
Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360: 57-58 (2002)
DOI
ScienceOn
|
31 |
Waffo-Teguo P, Hawthorne ME, Cuendet M, Merillon JM, Kinghorn AD, Pezzuto JM, Mehta RG. Potential cancerchemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures. Nutr. Cancer 40: 173-179 (2001)
DOI
ScienceOn
|
32 |
Fabris S, Momo F, Ravagnan G, Stevanato R. Antioxidant properties of resveratrol and piceid on lipid peroxidation in micelles and monolamellar liposomes. Biophys. Chem. 135: 76-83 (2008)
DOI
PUBMED
ScienceOn
|
33 |
Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50: 2094-2099 (2001)
DOI
ScienceOn
|
34 |
Ferrigi NR, McLanghlin JL, Powell RG, Smith CR. Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia Lagascae. J. Nat. Prod. 47: 347-352 (1984)
DOI
PUBMED
|
35 |
Romero-Perez AI, Ibern-Gomez M, Lamuela-Raventos RM, de la Torre-Boronat MC. Piceid, the major resveratrol derivative in grape juices. J. Agr. Food Chem. 47: 1533-1536 (1999)
DOI
ScienceOn
|
36 |
Thakkar K, Geahlen RL, Cushman M. Synthesis and proteintyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol. J. Med. Chem. 36: 2950-2955 (1993)
DOI
ScienceOn
|
37 |
Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95: 2409-2415 (1995)
DOI
ScienceOn
|